Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Seys, SF; Hellings, PW; Alobid, I; Backer, V; Bequignon, E; von, Buchwald, C; Cavaliere, C; Coste, A; Deneyer, L; Diamant, Z; Eckl-Dorna, J; Fokkens, WJ; Gane, S; Gevaert, P; Holbaek-Haase, C; Holzmeister, C; Hopkins, C; Hox, V; Huart, C; Jankowski, R; Jorissen, M; Kjeldsen, A; Knipps, L; Lange, B; van, der, Lans, R; Laulajainen-Hongisto, A; Larsen, K; Liu, DT; Lund, V; Mariën, G; Masieri, S; Mortuaire, G; Mullol, J; Reitsma, S; Rombaux, P; Schneider, S; Steinsvik, A; Tomazic, PV; Toppila-Salmi, SK; Van, Gerven, L; Van, Zele, T; Virkkula, P; Wagenmann, M; Bachert, C.
Chronic Rhinosinusitis Outcome Registry (CHRINOSOR): Establishment of an International Outcome Registry Driven by mHealth Technology.
J Allergy Clin Immunol Pract. 2023; 11(2):431-438.e2
Doi: 10.1016/j.jaip.2022.09.043
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Holzmeister Clemens
-
Tomazic Peter Valentin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BACKGROUND: Real-world evidence (RWE) is a valuable instrument to better understand the patient journey and effectiveness of therapies. RWE on the prevalence of uncontrolled chronic rhinosinusitis (CRS) and CRS natural course of disease across Europe is scarce. In addition, there is limited RWE that enables comparison of the effectiveness of marketed therapies including topical or systemic corticosteroids, sinus surgery, or biologics. OBJECTIVE: To establish an international CHRonic rhINOSinusitis Outcome Registry (CHRINOSOR) based on real-world data collection enabled by mobile health technology. METHODOLOGY: A digital platform, Galenus Health, supporting patients and physicians in the management of chronic respiratory diseases, is used to collect data on patient profile, disease history, patient outcomes, and a set of relevant clinical outcomes. Adult patients with a diagnosis of CRS are eligible for inclusion. RESULTS: A collaborative scientific network of 17 university ear-nose-throat (ENT) clinics from 10 European countries has been established with the aim to collect real-world data in a longitudinal and standardized manner. The Galenus Health digital platform is currently being implemented in these ENT clinics taking into account legal, privacy, and data security aspects. Up to 300 patients have already been included. CONCLUSIONS: CHRINOSOR is a collaborative effort that aims at improving our understanding of CRS, its comorbidities, and the effectiveness of its treatments. Ultimately, these insights will guide us as scientific community to develop future care pathways informed by RWE.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adult - administration & dosage
-
Humans - administration & dosage
-
Nasal Polyps - drug therapy
-
Rhinitis - therapy, drug therapy
-
Adrenal Cortex Hormones - therapeutic use
-
Sinusitis - therapy, drug therapy
-
Chronic Disease - administration & dosage
- Find related publications in this database (Keywords)
-
Chronic rhinosinusitis
-
Nasal polyps
-
Biologic therapy
-
Real-world evidence
-
Mobile health technology